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Summary
This study describes a novel T1-weighted MR molecular
imaging approach for sparse epitopes, such as the avb3-
integrin receptor in atherosclerotic angiogenesis, utiliz-
ing a soft Mn-based nanoparticle with high-relaxivity
a u g m e n t e db ym i n u t ea m o u n t so fs u r f a c eg a d o l i n i u m .
This new agent utilizes about 1/30th the amount of
lanthanide used for PFC paramagnetic particles and
reduces gadolinium exposure by 300-fold compared
with clinical single dose Gd-DTPA.
Background
We have previously reported in hyperlipidemic rabbit
models that integrin-targeted gadolinium perfluorocar-
bon nanoparticles can effectively assess plaque angio-
genesis using MRI. However, the concern for
Nephrogenic Systemic Fibrosis (NSF) has motivated the
development of alternative technologies that dramati-
cally lower Gd use. We have developed a manganese
oleate based nanoparticle with high longitudinal relaxiv-
ity for fibrin-specific imaging of thrombus. However, for
sparse receptors, such as neovascular integrins, preli-
minary studies revealed that paramagnetic nanoparticles
with greater T1w effects were needed. The objective of
this research was to evaluate a manganese-gadolinium
nanocolloid (MnGd NC) with gadolinium levels of less
than 300X current clinical dosage levels, while providing
high levels of T1-weighted MR imaging of sparse angio-
genic avb3-integrin expression in vivo.
Methods
A new nanocolloid comprised of a bivalent manganese
oleate (0.49±0.02 mg Mn/ml) /polysorbate core encap-
sulated with phospholipid surfactant enriched with 1.25
mole% Gd-DOTA-cholesterol and 0.3 mole% of quino-
lone-derived peptidomimetic avb3-integrin antagonist-
coupled to phosphatidylethanolamine through a PEG
(2000) spacer was produced (Diam., 134±2 nm.; Zeta,
-25±02mv; PDI, 0.13±0.03). Hyperlipidemic New Zeal-
and White rabbits (n=8), fed a 0.25% cholesterol diet
(egg-derived) for 12 months, received avb3-integrin-
MnGd NC or nontargeted MnGd NC; avb3-Integrin-
MnGd NC was also administered to rabbits fed a nor-
mal chow (n=4). Dynamic 3T MR imaging of the des-
cending thoracic aorta was performed over 2 hours
post-injection. Molecular imaging results were corrobo-
rated microscopically using fluoresence microscopy.
Results
MR signal enhancement at 2 hours was increased 18.7
±1.95% when averaged over all slices and voxels of the
aortic wall in hyperlipidemic rabbits treated with avb3-
integrin-MnGd NC. (Fig) Signal enhancement due to
nonspecific neovascular accumulation of nontargeted
MnGd NC was significantly less, (2.5±1.17%, p<0.05).
Rabbits fed a normal diet and treated with avb3-integ-
rin-MnGd NC had the signal increase, 3.17±1.94%,
which did not differ from the nontargeted control. The
MRI pattern observed was spatially heterogeneous along
both transverse and longitudinal planes of the descend-
ing aorta, and predominantly localized between the left
subclavian and the diaphragm. Immunohistochemistry
corroborated the prominent, neointimal proliferation
among cholesterol-fed, atherosclerotic rabbits and the
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mals. Fluorescently labeled avb3-integrin-MnGd NC
was localized to the advential neovessels of the lipid rich
plaques.
Conclusions
These data describe a novel T1-weighted MR molecular
imaging approach to detect sparse epitopes, such as the
avb3-integrin receptor in atherosclerotic angiogenesis,
which reduces the use of gadolinium by 300-fold of that
used clinically in a single dose Gd-DTPA contrast study.
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